| Website | micell.com |
| Category | BioTech |
| Phone | 919-313-2102 |
| Employees | |
| Founded | 1995 |
| Series B, 10/09 GE Capital St.Jude Medical Invemed Catalyst Fund | $15M |
Micell Technologies, Inc., a biomedical device company, develops interventional cardiology systems for vascular drug delivery. It develops MiStent, a drug-eluting stent that allows control of drug release and pharmacokinetics. The company was founded in 1995 and is based in Raleigh, North Carolina.
